Caracterisation of COVID-19 Patients Hospitalized in Infectious Disease Department

NCT04779021 | Unknown

• 1 other identifier: 21infectiocovid01
• Study Type: observational
• Target: 1,300
• Locations: 1 country
• Sites: 2

Brief Summary

The main objective of this cohort is to characterize COVID-19 patients hospitalized in infectious disease department. The collection of clinical and biological data from start of hospitalization to long-term follow up will contribute to a better description of the patient care, to the identification of predisposition to complication related to the disease, and to the evaluation of the impact of different therapeutical strategies.

Conditions

Covid19; SARS-CoV Infection

Outcome Measures

Primary Outcomes (3)

• Clinical characteristics

  Describe the clinical characteristic of patients hospitalized for SARS-CoV- 2 infection Identify factors associated with the COVID-19 disease severity

  34 months

• Biological characteristics

  Describe the biological characteristic of patients hospitalized for SARS-CoV- 2 infection Identify factors associated with the COVID-19 disease severity

  34 months

• Radiological characteristics

  Describe the radiological characteristic of patients hospitalized for SARS-CoV- 2 infection Identify factors associated with the COVID-19 disease severity

  34 months

Secondary Outcomes (6)

• Number of patient hospitalised for Covid-19

  34 months

• Overall Inpatient Mortality

  34 months

• Requirement for mechanical ventilation

  34 months

• ICU Length of Stay (LOS)

  34 months

• Evolution of patient general state during hospitalisation

  34 months

Interventions

Hospitalisation for SARS-COV2 infection OTHER

Patients hospitalized for SARS-COV2 infection

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

Patients hospitalized for SARS-COV2 infection

You may qualify if:

• Age \> or = to 18
• Patients hospitalised for SARS-CoV-2 infection confirmed by RT PCRand/or CT scan and/or serology

You may not qualify if:

• Patients for whom SARS-CoV-2 infection has not been confirmed

Sponsors & Collaborators

• Centre Hospitalier Universitaire de Nice: lead

Study Sites (2)

CHU de NICE - Infectiologie

Nice, 06200, France

RECRUITING

CHU de NICE - Urgences

Nice, 06200, France

RECRUITING

MeSH Terms

Conditions

COVID-19; Severe Acute Respiratory Syndrome

Interventions

Hospitalization

Condition Hierarchy (Ancestors)

Pneumonia, Viral; Pneumonia; Respiratory Tract Infections; Infections; Virus Diseases; Coronavirus Infections; Coronaviridae Infections; Nidovirales Infections; RNA Virus Infections; Lung Diseases; Respiratory Tract Diseases

Intervention Hierarchy (Ancestors)

Patient Care; Therapeutics; Health Services; Health Care Facilities Workforce and Services

Central Study Contacts

Michel CARLES

CONTACT

+33492035847; carles.m@chu-nice.fr

Elisa DEMONCHY

CONTACT

demonchy.e@chu-nice.fr

Study Design

• Study Type: observational
• Observational Model: COHORT
• Time Perspective: RETROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: February 23, 2021
• First Posted: March 3, 2021
• Study Start: February 15, 2020
• Primary Completion: December 31, 2021
• Study Completion: December 31, 2022
• Last Updated: March 3, 2021

Record last verified: 2021-02

Data Sharing

• IPD Sharing: Will not share

Locations

FR (2)